A novel understanding of postoperative complications: In vitro study of the impact of propofol on epigenetic modifications in cholinergic genes

PLoS One. 2019 May 29;14(5):e0217269. doi: 10.1371/journal.pone.0217269. eCollection 2019.

Abstract

Background: Propofol is a widely used anaesthetic drug with advantageous operating conditions and recovery profile. However, propofol could have long term effects on neuronal cells and is associated with post-operative delirium (POD). In this context, one of the contributing factors to the pathogenesis of POD is a reduction of cholinesterase activity. Accordingly, we investigated the effects of propofol on the methylation, expression and activity of cholinergic genes and proteins in an in-vitro model.

Results: We found that propofol indeed reduced the activity of AChE / BChE in our in-vitro model, without affecting the protein levels. Furthermore, we could show that propofol reduced the methylation of a repressor region of the CHRNA7 gene without changing the secretion of pro-or anti-inflammatory cytokines. Lastly, propofol changed the expression patterns of genes responsible for maintaining the epigenetic status of the cell and accordingly reduced the tri-methylation of H3 K27.

Conclusion: In conclusion we found a possible functional link between propofol treatment and POD, due to a reduced cholinergic activity. In addition to this, propofol changed the expression of different maintenance genes of the epigenome that also affected histone methylation. Thus, propofol treatment may also induce strong, long lasting changes in the brain by potentially altering the epigenetic landscape.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line, Tumor
  • Cholinergic Agents
  • Cholinergic Neurons / drug effects
  • Cholinesterases / genetics
  • Delirium / etiology
  • Epigenesis, Genetic / drug effects
  • Humans
  • Methyl Ethers
  • Methylation
  • Postoperative Complications / etiology*
  • Postoperative Period
  • Propofol / adverse effects*

Substances

  • Cholinergic Agents
  • Methyl Ethers
  • Cholinesterases
  • Propofol

Grants and funding

We acknowledge support by the DFG Open Access Publication Funds of the Ruhr-Universität Bochum and the Sophia and Frizu Heinemann-Stiftung of the RUHR-Universität Bochum. (www.rub.de)The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.